EyeBio raises $65m in Series A round: ‘Our goal is to build a broad and diverse pipeline of therapies for the eye’

EyeBio raises $65m in Series A round: ‘Our goal is to build a broad and diverse pipeline of therapies for the eye’

Submitted by admin on March 2, 2022 - 9:56am
Source: 
Biopharma Reporter
News Tags: 
EyeBio
funding
eye health
Headline: 
EyeBio raises $65m in Series A round: ‘Our goal is to build a broad and diverse pipeline of therapies for the eye’
snippet: 

Eyebiotech Limited, which was only founded in August last year, has just completed a successful US$65m Series A funding round.

Do Not Allow Advertisers to Use My Personal information